PROM1 and glioblastoma: Preliminary studies in glioblastoma demonstrate that BMP2, BMP4 and BMP7 treatment inhibits sphere forming and induces differentiation of CD133+ cells; moreover CD133+ cells pre-treatment with these cytokines attenuates tumor formation in mice [95-97].